Section Arrow
SRPT.NASDAQ
- Sarepta Therapeutics
Quotes are at least 15-min delayed:2026/03/05 14:15 EST
Regular Hours
Last
 16.1901
+0.1601 (+1.00%)
Day High 
16.61 
Prev. Close
16.03 
1-M High
19.75 
Volume 
1.14M 
Bid
16.19
Ask
16.23
Day Low
15.99 
Open
16.06 
1-M Low
15.7 
Market Cap 
1.68B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 17.59 
20-SMA 17.86 
50-SMA 20.16 
52-W High 103.3165 
52-W Low 10.415 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.83/2.90
Enterprise Value
3.01B
Balance Sheet
Book Value Per Share
12.60
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
301.03M
Operating Revenue Per Share
10.55
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
IBOImpact BioMedical Inc.0.6235+0.2102+50.86%-- 
QNCXQuince Therapeutics0.1065+0.0025+2.40%-- 
TNYATenaya Therapeutics0.7485+0.1596+27.10%-- 
GOSSGossamer Bio0.50565-0.07405-12.77%-- 
IOVAIovance Biotherapeutics4.295+0.055+1.30%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.